How to extend the use of grid-based interaction energy maps from chemistry to biotopics

ChemMedChem

Volumn 4, Issue 1, 2009, Pages 29-36

  Caron, Giulia ^a   Nurisso, Alessandra ^a   Ermondi, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Biocube4mf; Grid; Molecular interaction fields molecular modeling; Molecular recognition

Indexed keywords

1,4 DIHYDROPYRIDINE; AMLODIPINE; ANTHRAX TOXIN; BACTERIAL ANTIGEN; KV CHANNEL INTERACTING PROTEIN; LERCANIDIPINE; MEMBRANE PROTEIN; POTASSIUM CHANNEL; POTASSIUM ION; SODIUM ION;

ARTICLE; BACILLUS ANTHRACIS; DRUG SCREENING; MATHEMATICAL MODEL; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; RESEARCH; SURFACE PROPERTY;

AMINO ACID SUBSTITUTION; BACILLUS ANTHRACIS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DIHYDROPYRIDINES; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN STRUCTURE, TERTIARY; SOFTWARE; SULFOTRANSFERASES; THERMODYNAMICS;

EID: 58549114214     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200800259     Document Type: Article

References (27)

1. P. Murray-Rust, J. B. Mitchell, H. S. Rzepa, BMC Bioinf. 2005, 6, 141.
2. M. Baker, Nat. Rev Drug Discovery 2006, 5, 707-708.
3. G. Ermondi, G. Caron, Biochem. Pharmacol. 2006, 72, 1633-1645.
4. W. J. Geldenhuys, K. E. Gaasch, M. Watson, D. D. Allen, C.J. Van der Schyf, Drug Discov. Today 2006, 11, 127-132.
5. P. M. Dean in 3D QSAR in Drug Design (Ed.: H.Kubinyi), ESCOM, Leiden, 1993, pp. 150-172.
6. C. J. Miller, J. L. Elliot, R. J. Collier, Biochemistry 1999, 38, 10432-10441.
7. C. Petosa, R. J. Collier, K. R. Klimpei, S. H. Leppia, R. C. Liddington, Nature 1997, 385, 833-838.
8. M. W. H. Coughtrie, Pharmacogenomics J. 2002, 2, 297-308.
9. D. Bichet, M. Grabe, Y. N. Jan, L. Y. Jan, Proc. Natl. Acad. Sci. USA 2006, 103, 14 355-14 360.
10. L. Herbette, M. Vecchiarelli, A. Leonardi, J. Cardiovasc. Pharmacol. 1997, 29, S19-24.
11. T. F. Lüscher, F. Cosentino, Drugs 1998, 55, 509-517.
12. G. Caron, G. Ermondi in Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical and Computational Strategies (Eds.: B. Testa, S. Kraemer, H. Wunderli-Allenspach, G. Folkers), VHCA, Zurich, 2006, pp. 165-185.
13. R. P. Mason, S. F. Campbell, S.-D. Wang, L. G. Herbette, Mol. Pharmacol. 1989, 36, 634-640.
14. J. Gasteiger, CORINA 2004; http://www2.chemie.uni-erlangen.de/ software/corina/index. html.
15. J. Gasteiger, C. Rudolph, J. Sadowski, Tetrahedron Computer Methodology 1990, 3, 537-547.
16. E. Filipponi, V. Cecchetti, O. Tabarrini, D. Bonelli, A. Fravolini, J. Comput. Aided Mol. Des. 2000, 14, 277-291.
17. T. Naumann, H. Matter, J. Med. Chem. 2002, 45, 2366-2378.
18. M. Ridderstrom, I. Zamora, O. Fjellstrom, T. B. Andersson, J. Med. Chem. 2001 , 44, 4072-4081.
19. P. Crivori, G. Cruciani, P. A. Carrupt, B. Testa, J. Med. Chem. 2000, 43, 2204-2216.
20. C. Koukoulitsa, G. Geromichalos, H. Skaltsa, J. Comput. Aided Mol. Des. 2005, 19, 617-623.
21. G. Berellini, G. Cruciani, R. Mannhold, J. Med. Chem. 2005, 48, 4389-4399.
22. G. Klebe, Drug Discov. Today 2006, 11, 580-594.
23. Molecular Interaction Fields. Applications in Drug Discovery and ADME Prediction (Ed.: G.Cruciani), Wiley-VCH, Zürich, 2006.
24. G. Caron, G. Ermondi, J. Med. Chem. 2005, 48, 3269-3279.
25. P. Crivori, G. Cruciani, P. A. Carrupt, B. Testa, J. Med. Chem. 2000, 43, 2204-2216.
26. G. Cruciani, P. Crivori, P. A. Carrupt, B. Testa, J. Mol. Struct. THEOCHEM 2000, 503, 17-30.
27. G. Cianchetta, Y. Li, J. Kang, D. Rampe, D. Fravolini, G. Cruciani, R. J. Vaz, Bioorg. Med. Chem. Lett. 2005, 15, 3637-3642.